Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

The efficacy of hepatic 90Y resin radioembolization for metastatic neuroendocrine tumors: a meta-analysis.

Devcic Z, Rosenberg J, Braat AJ, Techasith T, Banerjee A, Sze DY, Lam MG.

J Nucl Med. 2014 Sep;55(9):1404-10. doi: 10.2967/jnumed.113.135855. Epub 2014 Jul 10.

2.

Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes.

Memon K, Lewandowski RJ, Mulcahy MF, Riaz A, Ryu RK, Sato KT, Gupta R, Nikolaidis P, Miller FH, Yaghmai V, Gates VL, Atassi B, Newman S, Omary RA, Benson AB 3rd, Salem R.

Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):887-94. doi: 10.1016/j.ijrobp.2011.07.041. Epub 2011 Dec 2.

3.

90Y Radioembolization after radiation exposure from peptide receptor radionuclide therapy.

Ezziddin S, Meyer C, Kahancova S, Haslerud T, Willinek W, Wilhelm K, Biersack HJ, Ahmadzadehfar H.

J Nucl Med. 2012 Nov;53(11):1663-9. doi: 10.2967/jnumed.112.107482. Epub 2012 Sep 17.

4.

90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience.

Rhee TK, Lewandowski RJ, Liu DM, Mulcahy MF, Takahashi G, Hansen PD, Benson AB 3rd, Kennedy AS, Omary RA, Salem R.

Ann Surg. 2008 Jun;247(6):1029-35. doi: 10.1097/SLA.0b013e3181728a45.

PMID:
18520231
5.

Factors predicting response and survival after yttrium-90 radioembolization of unresectable neuroendocrine tumor liver metastases: a critical appraisal of 48 cases.

Saxena A, Chua TC, Bester L, Kokandi A, Morris DL.

Ann Surg. 2010 May;251(5):910-6. doi: 10.1097/SLA.0b013e3181d3d24a.

PMID:
20395859
6.

Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases.

King J, Quinn R, Glenn DM, Janssen J, Tong D, Liaw W, Morris DL.

Cancer. 2008 Sep 1;113(5):921-9. doi: 10.1002/cncr.23685.

7.

Radioembolization of symptomatic, unresectable neuroendocrine hepatic metastases using yttrium-90 microspheres.

Paprottka PM, Hoffmann RT, Haug A, Sommer WH, Raessler F, Trumm CG, Schmidt GP, Ashoori N, Reiser MF, Jakobs TF.

Cardiovasc Intervent Radiol. 2012 Apr;35(2):334-42. doi: 10.1007/s00270-011-0248-1. Epub 2011 Aug 17.

PMID:
21847708
8.

Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases.

Jakobs TF, Hoffmann RT, Dehm K, Trumm C, Stemmler HJ, Tatsch K, La Fougere C, Murthy R, Helmberger TK, Reiser MF.

J Vasc Interv Radiol. 2008 Aug;19(8):1187-95. doi: 10.1016/j.jvir.2008.05.013. Epub 2008 Jun 27.

PMID:
18656012
9.

Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients.

Kennedy AS, Dezarn WA, McNeillie P, Coldwell D, Nutting C, Carter D, Murthy R, Rose S, Warner RR, Liu D, Palmedo H, Overton C, Jones B, Salem R.

Am J Clin Oncol. 2008 Jun;31(3):271-9. doi: 10.1097/COC.0b013e31815e4557.

PMID:
18525307
10.

Radioembolization as locoregional therapy of hepatic metastases in uveal melanoma patients.

Klingenstein A, Haug AR, Zech CJ, Schaller UC.

Cardiovasc Intervent Radiol. 2013 Feb;36(1):158-65. doi: 10.1007/s00270-012-0373-5. Epub 2012 Apr 21.

PMID:
22526099
11.

Radioembolization with yttrium microspheres for neuroendocrine tumour liver metastases.

Cao CQ, Yan TD, Bester L, Liauw W, Morris DL.

Br J Surg. 2010 Apr;97(4):537-43. doi: 10.1002/bjs.6931.

PMID:
20205229
12.

Yttrium-90 radioembolization is a safe and effective treatment for unresectable hepatocellular carcinoma: a single centre experience of 45 consecutive patients.

Saxena A, Meteling B, Kapoor J, Golani S, Danta M, Morris DL, Bester L.

Int J Surg. 2014 Dec;12(12):1403-8. doi: 10.1016/j.ijsu.2014.07.269. Epub 2014 Aug 1.

PMID:
25091398
13.

Radioembolization in patients with hepatic metastases from breast cancer.

Jakobs TF, Hoffmann RT, Fischer T, Stemmler HJ, Tatsch K, La Fougere C, Murthy R, Reiser MF, Helmberger TK.

J Vasc Interv Radiol. 2008 May;19(5):683-90. doi: 10.1016/j.jvir.2008.01.009. Epub 2008 Mar 19.

PMID:
18440456
14.

90Y Radioembolization Lung Shunt Fraction in Primary and Metastatic Liver Cancer as a Biomarker for Survival.

Xing M, Lahti S, Kokabi N, Schuster DM, Camacho JC, Kim HS.

Clin Nucl Med. 2016 Jan;41(1):21-7. doi: 10.1097/RLU.0000000000000915.

PMID:
26222534
15.

Yttrium-90 radioembolization for unresectable, chemoresistant breast cancer liver metastases: a large single-center experience of 40 patients.

Saxena A, Kapoor J, Meteling B, Morris DL, Bester L.

Ann Surg Oncol. 2014 Apr;21(4):1296-303. doi: 10.1245/s10434-013-3436-1. Epub 2013 Dec 15.

PMID:
24337647
16.

Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival.

Hoffmann RT, Paprottka PM, Schön A, Bamberg F, Haug A, Dürr EM, Rauch B, Trumm CT, Jakobs TF, Helmberger TK, Reiser MF, Kolligs FT.

Cardiovasc Intervent Radiol. 2012 Feb;35(1):105-16. doi: 10.1007/s00270-011-0142-x. Epub 2011 Mar 24.

PMID:
21431970
17.

Is yttrium-90 radioembolization a viable treatment option for unresectable, chemorefractory colorectal cancer liver metastases? A large single-center experience of 302 patients.

Saxena A, Meteling B, Kapoor J, Golani S, Morris DL, Bester L.

Ann Surg Oncol. 2015 Mar;22(3):794-802. doi: 10.1245/s10434-014-4164-x. Epub 2014 Oct 17.

PMID:
25323474
18.

Clinical and laboratory toxicity after intra-arterial radioembolization with (90)y-microspheres for unresectable liver metastases.

Smits ML, van den Hoven AF, Rosenbaum CE, Zonnenberg BA, Lam MG, Nijsen JF, Koopman M, van den Bosch MA.

PLoS One. 2013 Jul 24;8(7):e69448. doi: 10.1371/journal.pone.0069448. Print 2013. Erratum in: PLoS One. 2013;8(10). doi:10.1371/annotation/559e04cc-b09c-4b5c-9405-56837f6d5627.

19.

Integrating radioembolization into the treatment paradigm for metastatic neuroendocrine tumors in the liver.

Kennedy A, Coldwell D, Sangro B, Wasan H, Salem R.

Am J Clin Oncol. 2012 Aug;35(4):393-8. doi: 10.1097/COC.0b013e3182005768. Review.

PMID:
21278561
20.

Yttrium-90 radioembolization of renal cell carcinoma metastatic to the liver.

Abdelmaksoud MH, Louie JD, Hwang GL, Kothary N, Minor DR, Sze DY.

J Vasc Interv Radiol. 2012 Mar;23(3):323-30.e1. doi: 10.1016/j.jvir.2011.11.007. Epub 2012 Jan 25.

PMID:
22277275
Items per page

Supplemental Content

Write to the Help Desk